Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The present protocol describes the development of a reproducible murine model of spinal cord glioma by injecting tumor cells into the intervertebral space, offering a more effective and less invasive approach for research and therapeutic development.

Abstract

Spinal cord gliomas are commonly malignant tumors of the spinal cord, leading to a high rate of disability. However, uniform treatment guidelines and comprehensive data on spinal cord gliomas remain limited due to the lack of suitable preclinical animal models. Developing a simple and reproducible animal model has become essential for advancing basic and translational research. A murine model is ideal, as the murine spinal cord shares structural similarities with the human spinal cord. This protocol describes the generation of a reproducible murine model of spinal cord glioma by directly injecting tumor cells into the intervertebral space using the spinous process of the seventh cervical vertebra as a guide. Compared to other methods, this approach is more effective and convenient, involving a smaller incision, reduced invasiveness and blood loss, faster recovery, and more stable tumor formation. This model is expected to advance the understanding of disease mechanisms, optimize surgical strategies, and support the development of therapeutic drugs for spinal cord gliomas.

Introduction

Spinal cord gliomas, including those of the cauda equina, are commonly malignant neoplasms of the spinal cord, with 20%-40% classified as astrocytomas and the remainder as ependymomas1. Based on histological features, spinal cord gliomas are categorized into four grades (I-IV). Grade I and II tumors are considered low-grade gliomas, while grade III and IV tumors are classified as high-grade gliomas. Although spinal cord gliomas can occur at any segment of the spinal cord, they are most frequently found in the cervical region (33% of cases) and are relatively rare in other regions, with 26% of cases in the thoracic region a....

Protocol

This protocol was conducted in compliance with the guidelines approved by the Institutional Committee for the Ethics of Animal Care and Treatment in Biomedical Research at Capital Medical University (AEEI-2021-187). Female C57BL/6 mice, aged 8 weeks and weighing 19-21 g, were used in this study. The reagents and equipment utilized are detailed in the Table of Materials.

1. Pre-surgical preparation

  1. Clean and sterilize all surgical instruments thorou.......

Representative Results

To establish a stable and reliable animal model of spinal glioma, the intervertebral space between the sixth and seventh cervical vertebrae in C57BL/6 mice was identified as the ideal site for inoculation based on literature review and experimental findings10. The seventh cervical vertebra provides a distinct bony landmark, the spinous process (Figure 1G-I), which aids in accurately locating the injection site and stabilizing the inje.......

Discussion

Spinal cord glioma is the most common type of primary malignant tumor in the spinal cord, accounting for over 80% of intramedullary tumors. Pathologically, spinal cord gliomas are primarily classified as ependymomas or astrocytomas, with a particular focus on astrocytomas11. Among astrocytomas, some harbor H3K27M mutations, also known as diffuse midline gliomas (DMGs), which are associated with poor prognoses. A defining feature of spinal cord gliomas is their infiltrative growth pattern, which ma.......

Acknowledgements

This work was supported by the National Natural Science Foundation of China General Program (Fund No. 8207317). R&D Program of Beijing Municipal Education Commission (Fund No. KZ202210025040). Chinese Institutes for Medical Research, Beijing (Grant No. CX24PY08).

....

Materials

NameCompanyCatalog NumberComments
A nutritionally complete food and water gelled diet (Nutra-Gel)Bio-ServN/A
Adhesion microscope slidesCITOTEST188105
AffiniPure Fab Fragment Goat Anti-Mouse IgG (H+L)Jacksonimmuno115-007-003
B16-F10-lucProfessor Wang Xi's laboratoryN/A
Buprenorphine Related Compound ASigma-Aldrich457071-73-7
CD163 (ABT-CD163) mouse mAbImmunowayYM6146
CD86 rabbit pAbImmunowayYT7823
Cell counterBio-rad1450102
Cell Counting SlidesBiorad1450011
DAPI/Sealant Dual Solution (Anti-Quenching)ImmunowayYS0014
DilatorJinzhongD22178
D-LuciferinPerkinElmer122799
DMEMGibcoC11995500BT
D-PBSSolarbioD1040
Fetal Bovine Serum, qualifiedGibco10270-106
GL261-lucShanghai Zishi BiotechnologyN/A
Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488InvitrogenA11029
Goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 647LifeA21244
Goat SerumBeyotimeC0265
Hamilton microinjector 10 µL fixed 701NHamilton80383
In vivo bioluminescent imaging (IVIS Spectrum)PerkinElmerN/A
MethanolFuyu Chemical67-56-1
Micro ScissorsJinzhongWAA320
Microliter Syringes (10 µL, pointed tip)Shanghai GaogeN/A
Microscope cover glassCITOTEST10212440C
needle holder 12.5 cmJinzhongJCZ200
Ophthalmic Forceps 10 cmJinzhongJD1060
Ophthalmic Scissors 10 cmJinzhongY00030
PBS, 10×SolarbioP1022
Penicillin-Streptomycin LiquidSolarbioP1400
Scalpel BladesJinzhongJ0B050
super pap penZSGB-BioZLI-9303
Surgical Knife HandleJinzhongJ11010
Surgical scissors 12.5cm straight tipJinzhongJ21010
Suture needle with thread (medical silk) F303 3-0 75 cm figure-materials-39131/2 5×12 single 19mm blackShanghai Pudong Jinhuan Medical ProductsF303
Tissue-Tek O.C.T. CompoundSAKURA4583
TribromoethanolSigma-AldrichT48402
Triton X-100ServicebioGC204003
Trypan Blue Stain Solution, 0.4%SolarbioC0040
Trypsin Digestion solutions, 0.25% (without phenol red)SolarbioT1350
Tween-20SolarbioT8220

References

  1. Ostrom, Q. T. et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019. Neuro Oncol. 24 (Suppl 5), v1-v95 (2022).
  2. Kane, P. J., el-Mahdy, W., Singh, A., Powell, M. P., Crockard, H. A. Spinal intradural tumours: Part II--Intramedullary. Br J Neurosurg. 13 (6), 558-563 (1999).
  3. Horbinski, C. et al. NCCN guidelines insights: Central Nervous System Cancers, Version 2.2022. J Natl Compr Canc Netw. 21 (1), 12-20 (2023).
  4. Chai, R. C. et al. The molecular characteristics of spinal cord gliomas with or without H3 ....

Explore More Articles

Cancer ResearchSpinal cord gliomaTumor implantationGL261 lucB16 F10 luc

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved